Clinical Trials Browser

Phase 1/2 × Hamartoma Syndrome, Multiple × Sirolimus × Clear all

NCT06080165 2024-07-10

Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations

Phase 1/2 Withdrawn

Hamartoma Syndrome, Multiple